Hepatitis C Direct Acting Antiviral Therapies in a New York City HIV/AIDS Special Needs Plan: Uptake and Barriers

Abstract

Get full access to this article

View all access options for this article.

References

Kuehlkamp

, Schuelter-Trevisol

. Prevalence of human immunodeficiency virus/hepatitis C virus co-infection in Brazil and associated factors: A review. Braz J Infect Dis, 2013; 17:455–463.

Matthews

, Geretti

, Goulder

, et al. Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in Sub-Saharan Africa. J Clin Virol, 2014; 61:20–33.

Zhang

, Zhu

, Wu

, et al. HIV, hepatitis B virus, and hepatitis C virus co-infection in patients in the China National Free Antiretroviral Treatment Program, 2010-12: A retrospective observational cohort study. Lancet Infect Dis, 2014; 14:1065–1072.

Puoti

, Moioli

, Travi

, et al. The burden of liver disease in human immunodeficiency virus-infected patients. Semin Liver Dis, 2012; 32:103–113.

Smith

, Sabin

, Lundgren

, et al. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study. AIDS, 2010; 24:1537–1548.

Osinusi

, Townsend

, Kohli

, et al. Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection. JAMA, 2015; 313:1232–1239.

Sulkowski

, Hezode

, Gerstoft

, et al. Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir MK-5172 and elbasvir MK-8742 with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection C-WORTHY: A randomised, open-label phase 2 trial. Lancet, 2015; 385:1087–1097.

Sulkowski

, Naggie

, Lalezari

, et al. Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection. JAMA, 2014; 312:353–361.

ASLD, IDSA. Recommendations for Testing, Managing and Treating Hepatitis C. http://www.hcvguidelines.org. 2015 (Last accessed May 15, 2015 ).

10.

Bruggmann

, Litwin

. Models of care for the management of hepatitis C virus among people who inject drugs: One size does not fit all. Clin Infect Dis, 2013; 57:S56–S61.

11.

Fernandez-Montero

, Barreiro

, Vispo

, et al. Liver stiffness predicts liver-related complications and mortality in HIV patients with chronic hepatitis C on antiretroviral therapy. AIDS, 2013; 27:1129–1134.

12.

Kramer

, Kowalkowski

, Duan

, et al. The effect of HIV viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis C and HIV coinfection. J Acquir Immune Defic Syndr, 2015; 68:456–462.